British

pharmacopoeia
Appendices
Pharmacopoeia, Monogragh
• An official publication containing a list of medicinal drugs
with their effects and directions for their use.
• A pharmacopoeia, pharmacopeia, or pharmacopoea
(“drug-making standard”), is a book containing directions
for the identification of compound medicines, and
published by the authority of a government or a medical or
pharmaceutical society.
• A monograph includes the name of ingredients or
preparations; the definition, packaging, storage and labeling
requirements and requirements. The specification consists
of a series of tests, procedures for tests, and acceptance
criteria.
British pharmacopeia
• The British Pharmacopoeia (BP) is the national
pharmacopoeia of the United Kingdom. It is an
annually published collection of quality standards
for UK medicinal substances.
• It is a non-profit organisation that owns the
trademark and copyright.
• Latest edition:
• The BP 2020 is the latest edition of the British
Pharmacopoeia. This edition becomes legally
effective from 1 January 2020.
Editions of British
pharmacopeia
• Volumes I and II
Volumes
• Medicinal Substances
• Volume III
• Formulated Preparations
• Blood related Preparations
• Immunological Products
• Radiopharmaceutical Preparations
• Surgical Materials
• Homeopathic Preparations
• Volume IV
• Appendices
• Infrared Reference Spectra
• Index
• Volume V
• British Pharmacopoeia (Veterinary)
• Volume VI
• (CD-ROM version)
• British Pharmacopoeia
• British Pharmacopoeia (Veterinary)
• British Approved Names
Appendices and indices
Appendix 1: Interactions
Appendix 2: Borderline substances
Appendix 3: Cautionary and advisory labels for diapensed
medicines
Appendix 4: wound management products and
elasticated garments
• Dental practitioners' formulary
• Nurse prescribers' formulary
• Non-medical prescribing
• Special order manufacturers
Borderline substances
• Borderline substances are mainly foodstuffs, such as enteral feeds and
foods that are specially formulated for people with medical conditions.
• The Committee has recommended a number of products as complete
feeds for certain conditions.They may be prescribed both as sole
sources of nutrition and as necessary nutritional supplements
prescribable on medical grounds.
Definitions
1. The Committee has defined proven lactose or sucrose intolerance as
"A condition of intolerance to an intake of the relevant disaccharide
confirmed by:
2. The Committee has defined proven whole protein sensitivity as
"Intolerance to whole protein, proven by at least two withdrawal and
challenge tests, as suggested by an accurate dietary history."
Cautionary and advisory labels(CALs for
diapensed medicines
 wound management products and elasticated
garments
Cotton Absorbent cotton BP

Lint Absorbent lint BPC

Wound drainage pouches Biotrol draina S

Alginate dressings Sorbalgon

Hydrogel application Aquaform

Odour absorbent dressings CarboFLEX

Iodine dressings Iodosorb ointment

Permeable adhesive tapes Zinc oxide adhesive tape BP 1988

Dental and nurse prescribers'
formulary
• Aciclovir Cream BP
• Benzydamine Mouthwash, BP 0.15%
• Carbamazepine Tablets BP
• Diazepam Oral Solution BP 2mg/5ml
• Ephedrine Nasal Drops BP
• Fluconazole Oral Suspension 50mg/5ml DPF
• Hydrocortisone Cream BP 1%
• Ibuprofen Tablets BP
• Lansoprazole Capsules DPF
• Tetracycline Tablets BP
Non-medical prescribing
Special order manufacturers
• Licensed hospital manufacturing units also
manufacture ‘special-order’ products as unlicensed
medicines, the principal NHS units
• The MHRA recommends that an unlicensed
medicine should only be used when a patient has
special requirements that cannot be met by use of
a licensed medicine.